Number of the records: 1  

Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells

  1. 1.
    0541714 - ÚOCHB 2022 RIV CH eng J - Journal Article
    Hudáčová, M. - Hamuľaková, S. - Konkoľová, Eva - Jendželovský, R. - Vargová, J. - Ševc, J. - Fedoročko, P. - Soukup, O. - Janočková, J. - Ihnatová, V. - Kučera, T. - Bzonek, P. - Nováková, N. - Jun, D. - Junová, L. - Korábečný, J. - Kuča, K. - Kožurková, M.
    Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells.
    International Journal of Molecular Sciences. Roč. 22, č. 8 (2021), č. článku 3830. E-ISSN 1422-0067
    Institutional support: RVO:61388963
    Keywords : biscoumarin * Alzheimer’s disease * blood–brain barrier * cholinesterase * antiproliferative activity * A549
    OECD category: Biochemistry and molecular biology
    Impact factor: 6.208, year: 2021
    Method of publishing: Open access
    https://doi.org/10.3390/ijms22083830

    A series of novel C4-C7-tethered biscoumarin derivatives (12a–e) linked through piperazine moiety was designed, synthesized, and evaluated biological/therapeutic potential. Biscoumarin 12d was found to be the most effective inhibitor of both acetylcholinesterase (AChE, IC50 = 6.30 µM) and butyrylcholinesterase (BChE, IC50 = 49 µM). Detailed molecular modelling studies compared the accommodation of ensaculin (well-established coumarin derivative tested in phase I of clinical trials) and 12d in the human recombinant AChE (hAChE) active site. The ability of novel compounds to cross the blood–brain barrier (BBB) was predicted with a positive outcome for compound 12e. The antiproliferative effects of newly synthesized biscoumarin derivatives were tested in vitro on human lung carcinoma cell line (A549) and normal colon fibroblast cell line (CCD-18Co). The effect of derivatives on cell proliferation was evaluated by MTT assay, quantification of cell numbers and viability, colony-forming assay, analysis of cell cycle distribution and mitotic activity. Intracellular localization of used derivatives in A549 cells was confirmed by confocal microscopy. Derivatives 12d and 12e showed significant antiproliferative activity in A549 cancer cells without a significant effect on normal CCD-18Co cells. The inhibition of hAChE/human recombinant BChE (hBChE), the antiproliferative activity on cancer cells, and the ability to cross the BBB suggest the high potential of biscoumarin derivatives. Beside the treatment of cancer, 12e might be applicable against disorders such as schizophrenia, and 12d could serve future development as therapeutic agents in the prevention and/or treatment of Alzheimer’s disease.
    Permanent Link: http://hdl.handle.net/11104/0319265

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.